Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary: Global Psoriasis Treatment Market


4. Market Overview

4.1. Introduction

4.1.1. Market Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Psoriasis Treatment Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)


5. Key Insights

5.1. Regulatory Scenario by Region/Key Country

5.2. Psoriasis Treatment Market Pipeline Analysis

5.3. Key Mergers & Acquisitions


6. Global Psoriasis Treatment Market Analysis and Forecast, by Drug Class

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Psoriasis Treatment Market Value Forecast, by Drug Class, 2017–2027

6.3.1. TNF Inhibitors

6.3.2. Interleukin Inhibitors

6.3.3. Vitamin D Analogs

6.3.4. Corticosteroids

6.3.5. Others

6.4. Market Attractiveness, by Drug Class


7. Global Psoriasis Treatment Market Analysis and Forecast, by Route of Administration

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017–2027

7.3.1. Oral

7.3.2. Parenteral

7.3.3. Topical

7.4. Market Attractiveness By Route of Administration


8. Global Psoriasis Treatment Market Analysis and Forecast, by Distribution Channel

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017–2027

8.3.1. Hospital Pharmacies

8.3.2. Retail Pharmacies

8.3.3. Others

8.4. Market Attractiveness, by Distribution Channel


9. Global Psoriasis Treatment Market Analysis and Forecast, by Region

9.1. Key Findings

9.2. Psoriasis Treatment Market Value Forecast, by Region

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Market Attractiveness, by Region


10. North America Psoriasis Treatment Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. North America Psoriasis Treatment Market Value Forecast, by Drug Class, 2017–2027

10.2.1. TNF Inhibitors

10.2.2. Interleukin Inhibitors

10.2.3. Vitamin D Analogs

10.2.4. Corticosteroids

10.2.5. Others

10.3. North America Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017–2027

10.3.1. Oral

10.3.2. Parenteral

10.3.3. Topical

10.4. North America Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017–2027

10.4.1. Hospital Pharmacies

10.4.2. Retail Pharmacies

10.4.3. Others

10.5. North America Psoriasis Treatment Market Value Forecast, by Country/Sub-region, 2017–2027

10.5.1. U.S.

10.5.2. Canada

10.6. North America Psoriasis Treatment Market Attractiveness Analysis

10.6.1. By Drug Class

10.6.2. By Route of Administration

10.6.3. By Distribution Channel

10.6.4. By Country


11. Europe Psoriasis Treatment Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.1.2. Others

11.2. Europe Psoriasis Treatment Market Value Forecast, by Drug Class, 2017–2027

11.2.1. TNF Inhibitors

11.2.2. Interleukin Inhibitors

11.2.3. Vitamin D Analogs

11.2.4. Corticosteroids

11.2.5. Others

11.3. Europe Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017–2027

11.3.1. Oral

11.3.2. Parenteral

11.3.3. Topical

11.4. Europe Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017–2027

11.4.1. Hospital Pharmacies

11.4.2. Retail Pharmacies

11.4.3. Others

11.5. Europe Psoriasis Treatment Market Value Forecast, by Country/Sub-region, 2017–2027

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Rest of Europe

11.6. Europe Psoriasis Treatment Market Attractiveness Analysis

11.6.1. By Drug Class

11.6.2. By Route of Administration

11.6.3. By Distribution Channel

11.6.4. By Country/Sub-region


12. Asia Pacific Psoriasis Treatment Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Asia Pacific Psoriasis Treatment Market Value Forecast, by Drug Class, 2017–2027

12.2.1. TNF Inhibitors

12.2.2. Interleukin Inhibitors

12.2.3. Vitamin D Analogs

12.2.4. Corticosteroids

12.2.5. Others

12.3. Asia Pacific Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017–2027

12.3.1. Oral

12.3.2. Parenteral

12.3.3. Topical

12.4. Asia Pacific Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017–2027

12.4.1. Hospital Pharmacies

12.4.2. Retail Pharmacies

12.4.3. Others

12.5. Asia Pacific Psoriasis Treatment Market Value Forecast, by Country/Sub-region, 2017–2027

12.5.1. China

12.5.2. Japan

12.5.3. India

12.5.4. Australia & New Zealand

12.5.5. Rest of Asia Pacific

12.6. Asia Pacific Psoriasis Treatment Market Attractiveness Analysis

12.6.1. By Drug Class

12.6.2. By Route of Administration

12.6.3. By Distribution Channel

12.6.4. By Country/Sub-region

13. Latin America Psoriasis Treatment Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Latin America Psoriasis Treatment Market Value Forecast, by Drug Class, 2017–2027

13.2.1. TNF Inhibitors

13.2.2. Interleukin Inhibitors

13.2.3. Vitamin D Analogs

13.2.4. Corticosteroids

13.2.5. Others

13.3. Latin America Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017–2027

13.3.1. Oral

13.3.2. Parenteral

13.3.3. Topical

13.4. Latin America Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017–2027

13.4.1. Hospital Pharmacies

13.4.2. Retail Pharmacies

13.4.3. Others

13.5. Latin America Psoriasis Treatment Market Value Forecast, by Country/Sub-region, 2017–2027

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Latin America Psoriasis Treatment Market Attractiveness Analysis

13.6.1. By Drug Class

13.6.2. By Route of Administration

13.6.3. By Distribution Channel

13.6.4. By Country/Sub-region

14. Middle East & Africa Psoriasis Treatment Market Analysis and Forecast

14.1. Introduction

14.1.1. Key Findings

14.2. Middle East & Africa Psoriasis Treatment Market Value Forecast, by Drug Class, 2017–2027

14.2.1. TNF Inhibitors

14.2.2. Interleukin Inhibitors

14.2.3. Vitamin D Analogs

14.2.4. Corticosteroids

14.2.5. Others

14.3. Middle East & Africa Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017–2027

14.3.1. Oral

14.3.2. Parenteral

14.3.3. Topical

14.4. Middle East & Africa Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017–2027

14.4.1. Hospital Pharmacies

14.4.2. Retail Pharmacies

14.4.3. Others

14.5. Middle East & Africa Psoriasis Treatment Market Value Forecast, by Country/Sub-region, 2017–2027

14.5.1. GCC Countries

14.5.2. South Africa

14.5.3. Rest of Middle East & Africa

14.6. Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis

14.6.1. By Drug Class

14.6.2. By Route of Administration

14.6.3. By Distribution Channel

14.6.4. By Country/Sub-region


15. Competition Landscape

15.1. Market Share Analysis, by Company, 2018

15.2. Company Profiles

15.2.1. Amgen, Inc.

15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.1.2. Financial Overview

15.2.1.3. Product Portfolio

15.2.1.4. Strategic Overview

15.2.1.5. SWOT Analysis

15.2.2. Eli Lilly and Company

15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.2.2. Financial Overview

15.2.2.3. Product Portfolio

15.2.2.4. Strategic Overview

15.2.2.5. SWOT Analysis

15.2.3. Novartis AG

15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.3.2. Financial Overview

15.2.3.3. Product Portfolio

15.2.3.4. Strategic Overview

15.2.3.5. SWOT Analysis

15.2.4. Merck & Co., Inc.

15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.4.2. Financial Overview

15.2.4.3. Product Portfolio

15.2.4.4. Strategic Overview

15.2.4.5. SWOT Analysis

15.2.5. Johnson & Johnson

15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.5.2. Financial Overview

15.2.5.3. Product Portfolio

15.2.5.4. Strategic Overview

15.2.5.5. SWOT Analysis

15.2.6. Pfizer, Inc.

15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.6.2. Financial Overview

15.2.6.3. Product Portfolio

15.2.6.4. Strategic Overview

15.2.6.5. SWOT Analysis

15.2.7. AstraZeneca plc

15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.7.2. Financial Overview

15.2.7.3. Product Portfolio

15.2.7.4. Strategic Overview

15.2.7.5. SWOT Analysis

15.2.8. AbbVie, Inc.

15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.8.2. Financial Overview

15.2.8.3. Product Portfolio

15.2.8.4. Strategic Overview

15.2.8.5. SWOT Analysis

15.2.9. LEO Pharma A/S

15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.9.2. Financial Overview

15.2.9.3. Product Portfolio

15.2.9.4. Strategic Overview

15.2.9.5. SWOT Analysis

15.2.10. Biogen, Inc.

15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.10.2. Financial Overview

15.2.10.3. Product Portfolio

15.2.10.4. Strategic Overview

15.2.10.5. SWOT Analysis



List of Figures



Figure 01: Global Psoriasis Treatment Market Snapshot, 2018

Figure 02: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, 2017–2027

Figure 04: Global Psoriasis Treatment Market Value Share, by Route of Administration, 2018

Figure 06: Global Psoriasis Treatment Market Value Share, by Region, 2018

Figure 03: Global Psoriasis Treatment Market Value Share, by Drug Class, 2018

Figure 05: Global Psoriasis Treatment Market Value Share, by Distribution Channel, 2018

Figure 07: Regulatory Approval Process - U.S.

Figure 08: Regulatory Approval Process - Europe

Figure 09: Regulatory Approval Process - Japan

Figure 10: Global Psoriasis Treatment Market Value Share, by Drug Class, 2018 and 2027

Figure 11: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by TNF Inhibitors, 2017–2027

Figure 12: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Interleukin Inhibitors, 2017–2027

Figure 13: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vitamin D Analogs, 2017–2027

Figure 14: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Corticosteroids, 2017–2027

Figure 15: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 16: Global Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2019–2027

Figure 17: Global Psoriasis Treatment Market Value Share, by Route of Administration, 2018 and 2027

Figure 18: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oral, 2017–2027

Figure 19: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Parenteral, 2017–2027

Figure 20: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Topical, 2017–2027

Figure 21: Global Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027

Figure 22: Global Psoriasis Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 23: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2017–2027

Figure 24: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017–2027

Figure 25: Global Psoriasis Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 26: Global Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 27: Global Psoriasis Treatment Market Value Share, by Region, 2018 and 2027

Figure 28: Global Psoriasis Treatment Market Attractiveness Analysis, by Region, 2019–2027

Figure 29: North America Psoriasis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

Figure 30: North America Psoriasis Treatment Market Attractiveness Analysis, by Country, 2019–2027

Figure 31: North America Psoriasis Treatment Market Value Share, by Drug Class, 2018 and 2027

Figure 32: North America Psoriasis Treatment Market Value Share, by Route of Administration, 2018 and 2027

Figure 33: North America Psoriasis Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 34: North America Psoriasis Treatment Market Value Share Analysis, by Country, 2018 and 2027

Figure 35: North America Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2019–2027

Figure 36: North America Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027

Figure 37: North America Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 38: Europe Psoriasis Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 39: Europe Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 40: Europe Psoriasis Treatment Market Value Share, by Drug Class, 2018 and 2027

Figure 41: Europe Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2019–2027

Figure 42: Europe Psoriasis Treatment Market Value Share, by Route of Administration, 2018 and 2027

Figure 43: Europe Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration

Figure 44: Europe Psoriasis Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 45: Europe Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 46: Europe Psoriasis Treatment Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 47: Asia Pacific Psoriasis Treatment Market Value (US$ Mn) Forecast, 2017–2027

Figure 48: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 49: Asia Pacific Psoriasis Treatment Market Value Share, by Drug Class, 2018 and 2027

Figure 50: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2019–2027

Figure 51: Asia Pacific Psoriasis Treatment Market Value Share, by Route of Administration, 2018 and 2027

Figure 52: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027

Figure 53: Asia Pacific Psoriasis Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 54: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 55: Asia Pacific Psoriasis Treatment Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 56: Latin America Psoriasis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

Figure 57: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 58: Latin America Psoriasis Treatment Market Value Share, by Drug Class, 2018 and 2027

Figure 59: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2019–2027

Figure 60: Latin America Psoriasis Treatment Market Value Share, by Route of Administration, 2018 and 2027

Figure 61: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration

Figure 62: Latin America Psoriasis Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 63: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel

Figure 64: Latin America Psoriasis Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 65: Middle East & Africa Psoriasis Treatment Market Value (US$ Mn) Forecast, 2017–2027

Figure 66: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 67: Middle East & Africa Psoriasis Treatment Market Value Share, by Drug Class, 2018 and 2027

Figure 68: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Drug Class, 2019–2027

Figure 69: Middle East & Africa Psoriasis Treatment Market Value Share, by Route of Administration, 2018 and 2027

Figure 70: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027

Figure 71: Middle East & Africa Psoriasis Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 72: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 73: Middle East & Africa Market Value Share, by Country/Sub-region, 2018 and 2027


List of Tables



Table 01: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 02: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 03: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 04: Global Psoriasis Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 05: North America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 06: North America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 07: North America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 08: North America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 09: Europe Psoriasis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 10: Europe Psoriasis Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 11: Europe Psoriasis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 12: Europe Psoriasis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 13: Asia Pacific Psoriasis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 14: Asia Pacific Psoriasis Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 15: Asia Pacific Psoriasis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 16: Asia Pacific Psoriasis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 17: Latin America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 18: Latin America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 19: Latin America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 20: Latin America Psoriasis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 21: Middle East & Africa Psoriasis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 22: Middle East & Africa Psoriasis Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 23: Middle East & Africa Psoriasis Treatment Market Value(US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 24: Middle East & Africa Psoriasis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027